Patent Assignment
Reel/Frame 073831/0819
Change of Name
Recorded: 2025-12-03
Pages: 4
Assignor
PIONEERING MEDICINES 08-B, INC.
Executed: 2025-04-28
Assignee
FLAGSHIP LABS 114, INC.
55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Tissue-Specific Nucleic Acid Delivery by Mixed Cationic Lipid Particles
Application:
18/556,563 →
Publication:
US 2024/0197636
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Feb 10, 2025
From: OMEGA THERAPEUTICS, INC.
To: PIONEERING MEDICINES 08- B, INC.
Reel/Frame 070167/0243 →
Assignment of Assignor's Interest
Dec 3, 2025
From: PATIL, VISHWESH ASHOK; SARISOZEN, CAN; COSTA, DANIEL FERREIRA GOMES
To: OMEGA THERAPEUTICS, INC.
Reel/Frame 073099/0706 →
Assignment of Assignor's Interest
Dec 3, 2025
From: OMEGA THERAPEUTICS, INC.
To: PIONEERING MEDICINES 08-B, INC.
Reel/Frame 073100/0505 →
Change of Name
Jan 6, 2026
From: PIONEERING MEDICINES 08-B, INC.
To: FLAGSHIP LABS 114, INC.
Reel/Frame 074205/0810 →
Change of Name
Feb 3, 2026
From: FLAGSHIP LABS 114, INC.
To: SEPIA THERAPEUTICS, INC.
Reel/Frame 074275/0374 →